Through a new five-year award from PEPFAR through the Centers for Disease Control and Prevention (CDC), ICAP will continue its partnership with the Government of Mozambique to lead a second transformational scale up of HIV services that is necessary to achieve control of the epidemic.

Working in partnership with the Ministry of Health (MOH), ICAP will provide technical assistance, capacity building, and program implementation support to provincial and district health directorates in Nampula and Zambézia provinces. At the facility and community level, efforts will aim to intensify and focus HIV prevention, adult and pediatric care, and voluntary medical male circumcision services. To advance TB care through HIV services, ICAP will tailor service delivery to optimize case identification and patient retention across the care cascades. At the national level, ICAP will work with the MOH to increase capacity for service delivery, stewardship, and continuous quality improvement.

There are an estimated 1.5 million people living with HIV in Mozambique, and HIVprevalence is estimated at 10.6 percent. Mozambique has made important strides, however, in expanding access to HIV testing and antiretroviral therapy, and new HIV infections among adults are down by 40 percent from 2004. Tuberculosis (TB) also poses a public health challenge, and Mozambique is one of the world’s 22 High Burden Countries, according to the World Health Organization.

This new project will draw upon ICAP’s experience and scientific leadership in Mozambique, as a PEPFAR implementing partner since 2004, working hand-in-hand with the MOH.

“ICAP is honored to continue this important work with the Ministry of Health,” said Dr. Antonio Mussa, ICAP country director. “We will take forward our successful partnerships and interventions in the two target provinces and work together to drive Mozambique’s achievement of the 90-90-90 goals.”